Sunday, May 31, 2015

Study identifies possible new combination chemotherapy for patients with advanced prostate cancer

… patients with advanced metastatic castration-resistant prostate cancer (mCRPC) have relied on the … prostate-specific antigen (PSA) and bone-specific alkaline phosphatase (BAP, a marker of prostate cancer … developing tumor-specific biomarkers to identity patients with an aggressive variant of prostate cancer

No comments:

Post a Comment